ISO/TR 12417-2:2022
Current
The latest, up-to-date edition.
Cardiovascular implants and extracorporeal systems — Vascular device-drug combination products — Part 2: Local regulatory information
Hardcopy , PDF , PDF 3 Users , PDF 5 Users , PDF 9 Users
English
07-07-2022
Important note : All end users must be registered with an Account prior to user licenses being assigned.
This document provides region-specific information for:
— local submissions and approvals for vascular device-drug combination products (VDDCPs) in countries and regions around the world;
— changes related to the drug-containing part and how they are evaluated by different local regions.
For implanted products, this document is considered as a supplement to ISO14630, which specifies general requirements for the performance of non-active surgical implants.
This document is considered also as a supplement to ISO12417-1, and any relevant device-specific standards, such as the ISO25539 series specifying requirements for endovascular devices. This document also addresses VDDCPs that are not necessarily permanent implants.
| DocumentType |
Technical Report
|
| Pages |
29
|
| PublisherName |
International Organization for Standardization
|
| Status |
Current
|
| Supersedes |
| Standards | Relationship |
| IS 17751 : Part 2 : 2024 | Identical |
Access your standards online with a subscription
Features
-
Simple online access to standards, technical information and regulations.
-
Critical updates of standards and customisable alerts and notifications.
-
Multi-user online standards collection: secure, flexible and cost effective.